Tap on and choose 'Add to Home Screen' to create a shortcut app

Tap on and choose 'Add to Home Screen/Install App' to create a shortcut app

References for High-Grade Gliomas in Children

This page was last updated on April 8th, 2024

  1. Pollack IF: Brain tumors in children. N Engl J Med 331:1500-1507, 1994
  2. Tamber MS, Rutka JT: Pediatric supratentorial high-grade gliomas. Neurosurg Focus 14 (2):e1, 2003
  3. CBTRUS. Statistical Report: Primary Brain Tumors in the United States, 1998-2002. Hinsdale, IL: Central Brain Tumor Registry of the United States, 2005
  4. Broniscer A, Gajjar A: Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist. Oncologist 9:197-206, 2004
  5. Song KS, Phi JH, Cho BK, et al: Long-term outcomes in children with glioblastoma. J Neurosurg Pediatr 6:145-149, 2010
  6. Schlehofer B, Hettinger I, Ryan P, et al: Occupational risk factors for low grade and high grade glioma: results from an international case control study of adult brain tumours. Int J Cancer 113:116-125, 2005
  7. Kranzinger M, Jones N, Rittinger O, et al: Malignant glioma as a secondary malignant neoplasm after radiation therapy for craniopharyngioma: report of a case and review of reported cases. Onkologie 24:66-72, 2001
  8. Kleihues P, Burger PC, Rosenblum, et al: Anaplastic astrocytoma, in Louis DN OH, Wiestler OD, Cavenee WK (eds): World Health Organization Classification of Tumours of the Central Nervous System, ed 4. Lyon: International Agency for Research on Cancer, 2007, pp 30-32
  9. Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumours. Brain Pathol 3:255-268, 1993
  10. Kleihues P, Burger PC, Aldape, KD, et al: Glioblastoma, in Louis DN OH, Wiestler OD, Cavenee WK (eds): World Health Organization Classification of Tumours of the Central Nervous System, ed 4. Lyon: International Agency for Research on Cancer, 2007, pp 164-172
  11. Suri V, Das P, Pathak P, et al: Pediatric glioblastomas: a histopathological and molecular genetic study. Neuro Oncol 11:274-280, 2009
  12. Ohgaki H, Eibl RH, Schwab M, et al: Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system. Mol Carcinog 8:74-80, 1993
  13. Ichimura K, Schmidt EE, Miyakawa A, et al: Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades. Genes Chromosomes Cancer 22:9-15, 1998
  14. Dropcho EJ, Wisoff JH, Walker RW, et al: Supratentorial malignant gliomas in childhood: a review of fifty cases. Ann Neurol 22:355-364, 1987
  15. Howe FA, Opstad KS: 1H MR spectroscopy of brain tumours and masses. NMR Biomed 16:123-131, 2003
  16. Billingsley RL, Lang FF, Slopis JM, et al: Visual-spatial neglect in a child following sub-cortical tumor resection. Dev Med Child Neurol 44:191-199, 2002
  17. Sposto R, Ertel IJ, Jenkin RD, et al: The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. J Neurooncol 7:165-177, 1989
  18. Finlay JL, Boyett JM, Yates AJ, et al: Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. J Clin Oncol 13:112-123, 1995
  19. Stupp R, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005
  20. Lashford LS, Thiesse P, Jouvet A, et al: Temozolomide in malignant gliomas of childhood: a United Kingdom Children’s Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. J Clin Oncol 20:4684-4691, 2002
  21. Cohen KJ, Pollack IF, Zhou T, et al: Temozolomide in the treatment of high-grade gliomas in children: a report from the Children’s Oncology Group. Neuro Oncol 13:317-323, 2011
  22. Massimino M, Gandola L, Luksch R, et al: Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade glioma. Neuro Oncol 7:41-48, 2005
  23. Reddy AT, Wellons JC, 3rd: Pediatric high-grade gliomas. Cancer J 9:107-112, 2003
  24. Hodgson DC, Goumnerova LC, Loeffler JS, et al: Radiosurgery in the management of pediatric brain tumors. Int J Radiat Oncol Biol Phys 50:929-935, 2001
  25. Tarapore P, Banerjee A, Gupta N: Supratentorial high-grade gliomas, in Tonn J, Westphal, M, Rutka, JR (eds): Oncology of CNS Tumors, ed 2. Berlin Heidelberg: Springer-Verlag, 2010, pp 427-434
  26. Baumann GS, Wara WM, Larson DA, et al: Gamma knife radiosurgery in children. Pediatr Neurosurg 24:193-201, 1996
  27. Chow KH, Gottschalk S: Cellular immunotherapy for high-grade glioma. Immunotherapy 3:423-434, 2011
  28. Driggers L, Zhang JG, Newcomb EW, et al: Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper. J Neurooncol 97:159-169, 2010
  29. Allen JC: Complications of chemotherapy in patients with brain and spinal cord tumors. Pediatr Neurosurg 17:218-224, 1991
  30. Neervoort FW, Van Ouwerkerk WJR, Folkersman H, et Al: Surgical morbidity and mortality of pediatric brain tumors: a single center audit. Childs Nerv Syst. 26:1583–1592, 2010
  31. Gururangan S, Chi SN, Young Poussaint T, et al: Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study. J Clin Oncol 28:3069-3075, 2010
  32. Bobo RH, Laske DW, Akbasak A, et al: Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA 91:2076-2080, 1994
  33. Ries LAG, Smith MA, Gurney JG, et al (eds): Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Bethesda, MD, 1999
  34. MacDonald TJ, Arenson EB, Ater J, et al: Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children’s Cancer Group Study 9933. Cancer 104: 2862-2871, 2005
  35. Musial-Bright L, Fengler R, Henze G, et al: Carboplatin and ototoxicity: hearing loss among survivors of childhood medulloblastoma. Childs Nerv Syst 27:407-413, 2011
  36. Vauleon E, Avril T, Collet B, et al: Overview of cellular immunotherapy for patients with glioblastoma. Clin Dev Immunol 2010, Article ID 689171: 1-18
  37. Wisoff JH, Boyett JM, Berger MS, et al: Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children’s Cancer Group trial no. CCG-945. J Neurosurg 89:52-59, 1998
  38. Phuphanich S, Edwards MS, Levin VA, et al: Supratentorial malignant gliomas of childhood. Results of treatment with radiation therapy and chemotherapy. J Neurosurg 60:495-499, 1984